Vycor Medical Stock Probability of Future OTC Stock Price Finishing Under 0.078
| VYCO Stock | USD 0.07 0.00 0.00% |
Vycor |
Vycor Medical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Vycor Medical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Vycor Medical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Vycor Medical is way too risky over 90 days horizon | |
| Vycor Medical has some characteristics of a very speculative penny stock | |
| Vycor Medical appears to be risky and price may revert if volatility continues | |
| Vycor Medical has a very high chance of going through financial distress in the upcoming years | |
| Vycor Medical has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Vycor Medical currently holds 150 K in liabilities with Debt to Equity (D/E) ratio of 390.9, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Vycor Medical has a current ratio of 0.15, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Vycor Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Vycor Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Vycor Medical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Vycor to invest in growth at high rates of return. When we think about Vycor Medical's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 1.39 M. Net Loss for the year was (435.66 K) with profit before overhead, payroll, taxes, and interest of 1.26 M. | |
| About 65.0% of Vycor Medical outstanding shares are owned by insiders |
Vycor Medical Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Vycor OTC Stock often depends not only on the future outlook of the current and potential Vycor Medical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Vycor Medical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 30.8 M | |
| Short Long Term Debt | 640.2 K | |
| Shares Float | 12.1 M |
Vycor Medical Technical Analysis
Vycor Medical's future price can be derived by breaking down and analyzing its technical indicators over time. Vycor OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Vycor Medical. In general, you should focus on analyzing Vycor OTC Stock price patterns and their correlations with different microeconomic environments and drivers.
Vycor Medical Predictive Forecast Models
Vycor Medical's time-series forecasting models is one of many Vycor Medical's otc stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Vycor Medical's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.
Things to note about Vycor Medical
Checking the ongoing alerts about Vycor Medical for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Vycor Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Vycor Medical is way too risky over 90 days horizon | |
| Vycor Medical has some characteristics of a very speculative penny stock | |
| Vycor Medical appears to be risky and price may revert if volatility continues | |
| Vycor Medical has a very high chance of going through financial distress in the upcoming years | |
| Vycor Medical has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Vycor Medical currently holds 150 K in liabilities with Debt to Equity (D/E) ratio of 390.9, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Vycor Medical has a current ratio of 0.15, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Vycor Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Vycor Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Vycor Medical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Vycor to invest in growth at high rates of return. When we think about Vycor Medical's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 1.39 M. Net Loss for the year was (435.66 K) with profit before overhead, payroll, taxes, and interest of 1.26 M. | |
| About 65.0% of Vycor Medical outstanding shares are owned by insiders |
Other Information on Investing in Vycor OTC Stock
Vycor Medical financial ratios help investors to determine whether Vycor OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Vycor with respect to the benefits of owning Vycor Medical security.